Multiple Assemblies exist for SMTL entry 9i7y
Crystal Structure of KRasG13C in Complex with Nucleotide-based Covalent Inhibitor 7b; X-RAY DIFFRACTION 1.85 Å

	SMTL ID 9i7y.1 Ligands [(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-4-oxidanyl-2-[[oxidanyl(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] (3~{S})-3-(propanoylamino)piperidine-1-carboxylate; MAGNESIUM ION Polypeptides Isoform 2B of GTPase KRas Oligo-state monomer
	SMTL ID 9i7y.2 Ligands [(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-4-oxidanyl-2-[[oxidanyl(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] (3~{S})-3-(propanoylamino)piperidine-1-carboxylate; MAGNESIUM ION Polypeptides Isoform 2B of GTPase KRas Oligo-state monomer
	SMTL ID 9i7y.3 Ligands [(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-4-oxidanyl-2-[[oxidanyl(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] (3~{S})-3-(propanoylamino)piperidine-1-carboxylate; MAGNESIUM ION Polypeptides Isoform 2B of GTPase KRas Oligo-state monomer